Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.3700
+0.0050 (1.37%)
Jun 3, 2026, 3:58 PM AEST
Island Pharmaceuticals Market Cap
Island Pharmaceuticals has a market cap or net worth of 109.49 million as of June 3, 2026. Its market cap has increased by 225.46% in one year.
Market Cap
109.49M
Enterprise Value
102.62M
Revenue
62.85K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since April 13, 2021, Island Pharmaceuticals's market cap has increased from 42.51M to 109.49M, an increase of 157.57%. That is a compound annual growth rate of 20.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 108.01M | -6.64% |
| Dec 31, 2025 | 115.69M | 274.76% |
| Dec 31, 2024 | 30.87M | 299.86% |
| Dec 29, 2023 | 7.72M | -48.65% |
| Dec 28, 2022 | 15.03M | -27.45% |
| Dec 31, 2021 | 20.72M | -51.25% |
| Apr 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recce Pharmaceuticals | 159.05M |
| Actinogen Medical | 136.47M |
| Nyrada | 122.47M |
| Dimerix | 111.07M |
| Alterity Therapeutics | 97.88M |
| Paradigm Biopharmaceuticals | 86.70M |
| Arovella Therapeutics | 85.82M |
| Prescient Therapeutics | 82.02M |